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Biodegradable and biocompatible poly(amidoamine)-(PAA-) based hydrogels have been considered for diﬀerent tissue engineering
applications. First-generation AGMA1 hydrogels, amphoteric but prevailing cationic hydrogels containing carboxylic and
guanidine groups as side substituents, show satisfactory results in terms of adhesion and proliferation properties towards diﬀerent
cell lines. Unfortunately, these hydrogels are very swellable materials, breakable on handling, and have been found inadequate for
other applications. To overcome this problem, second-generation AGMA1 hydrogels have been prepared adopting a new synthetic
method. These new hydrogels exhibit good biological properties in vitro with satisfactory mechanical characteristics. They are
obtained in diﬀerent forms and shapes and successfully tested in vivo for the regeneration of peripheral nerves. This paper reports
on our recent eﬀorts in the use of first-and second-generation PAA hydrogels as substrates for cell culturing and tubular scaﬀold
for peripheral nerve regeneration.
1. Introduction
Tissue loss or end-stage organ failure caused by injury or
other types of damage is one of the most devastating and
costly problems in human health care. Surgical strategies
that have been developed to address these problems include
organ transplantation from one individual to another, tissue
transfer from a healthy site to the diseased site in the same
individual, and replacement by using mechanical devices
such as joint prosthesis or dialysis machine. Moreover, med-
ical treatment encompassed supplementation of metabolic
products of the nonfunctional tissue. Though significant
advances have been achieved in terms of health care by these
therapeutic options, many limitations and unsolved issues
remain [1]. The number of organs available for transplan-
tation is far exceeded by the number of patients needing
such procedures. In Europe in 2010 alone, approximately
9,300 people were on the waiting list for an organ transplant
due to end-stage organ failure, but only 3,100 transplants
were performed [2]. Tissue transfer cannot replace all the
functions of the original tissue and bears the risk of donor-
site complications.
Tissue engineering “is an interdisciplinary field that
applies the principles of engineering and of life science
towards the development of biological substitutes that
restore, maintain or improve tissue or organ function.” This
definition is based on several articles, by Langer and Vacanti,
that were published in the 1990s [3–6]. In those articles
tissue engineering is proposed as an alternative to organ
transplantation when all the other treatments fail using
three main strategies. The first, the utilization of isolated
cells, which has the great advantage to replace just the
cells that are really needed and to eventually genetically
manipulate them before infusion. This strategy allows for
minimal invasive surgery, but there is always the possibility
of immunological rejection or failure in maintaining new
functions. The second approach is that of using tissue-
inducing substances such as growth factors or cytokines.
However, drawbacks of this solution are purification and
large-scale production issues, and it is always necessary to
have a system to deliver the bioactive molecule to its target.
Finally, the third strategy utilizes cells placed on a scaﬀold
that serve as a synthetic extracellular matrix to organize cells
into a three-dimensional architecture and to present stimuli
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Scheme 1: Synthesis of linear PAAs. R1, R2, R3, and R4 can be any alkyl residues eventually containing carboxyl, amide, ester, and ether
groups.
Table 1: Acid-base properties of the same PAA polymers.
PAA name and structure pKa I.P.
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which direct the growth and formation of a desired tissue [7].
This strategy is currently used in tissue engineering.
Scaﬀolds can be produced from natural materials or
synthetic polymers. In general, the ideal scaﬀold should be
three dimensional, highly porous with an interconnected
pore network, and biocompatible with a controlled degra-
dation rate, should have an appropriate surface for cell adhe-
sion, proliferation, and diﬀerentiation, and should maintain
proper mechanical properties. Among all the synthetic
polymeric materials that have been found to be suitable for
tissue engineering applications, special attention has been
recently given to biodegradable polymers and hydrogels.
Several reviews in literature the describe the use of natural
[8–15] and synthetic [16–20] biodegradable polymers as well
as some nonbiodegradable [21, 22] ones, which are currently
used for cartilage, nerve repair, bone, cardiac, vascular graft,
and many other tissue engineering applications. Among syn-
thetic materials, increasing attention has been paid to hydro-
gels due to their tissue-like properties for interaction with
living cells, such as similar water content and permeability to
oxygen andmetabolites [23]. Synthetic hydrogels, as opposed
to naturally derived materials, are more advantageous, giving
the possibility of a complete control over hydrogel compo-
sition, surface properties, and other key parameters such
as water absorption and (bio)degradation time. Moreover,
hydrogel structures could be used to encapsulate cells, pro-
teins, and signaling factors, as well as bioactive moieties to be
slowly released during cell growth [24]. This paper reports on
our recent eﬀorts in the use of first-and second-generation
poly(amidoamine) hydrogels as substrates for cell culturing
and tubular scaﬀold for peripheral nerve regeneration.
2. Poly(amidoamine) Hydrogels:
Synthesis and Properties
PAAs are a family of synthetic polymers containing tertiary
amino and amido groups regularly arranged along their
polymer chain [25, 26]. They are obtained by Michael-
type polyaddition of primary or secondary amines to bis-
acrylamides (Scheme 1).
PAAs are extremely versatile materials. PAAs containing
as side substituents other chemical functions, such as
additional tertiary amino groups, carboxyl groups, hydroxyl
groups, and allyl groups, can be easily obtained by using
suitably functionalized monomers, as for instance amino-
carbohydrate derivatives [27]. Peptides and proteins can
also participate in the polyaddition reaction through their
terminal amino groups as well as ε-lysine amino groups,
if present [26–28]. Many PAAs exhibit a combination of
properties imparting them a considerable potential in
the biomedical field (see Table 1). They are highly hydro-
philic and usually degrade in aqueous media at a rate
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Scheme 2: General synthesis of PAA-based hydrogels.
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Scheme 3: Synthesis of PAA hydrogels using NH2–BAC.
depending on their structure [29]. Moreover, many of them
are almost nontoxic, in spite of their polycationic nature,
with IC50 values ranging from 0.5 to 3.0mg/mL [30, 31].
Amphoteric PAAs, that is, PAAs carrying carboxyl groups
as side substituents, are even less toxic and may be approxi-
mately as biocompatible as dextran [32].
Crosslinked PAAs can be easily obtained by diﬀerent
methods. So far, the most often employed method is to
introduce primary diamines as crosslinking agents into the
polymerization mixture [33]. Primary diamines carry four
diﬀerent mobile hydrogens and hence behave as tetrafunc-
tional monomers in PAA synthesis (Scheme 2). Crosslinked
PAAs are typical hydrogels, absorbing large amounts of water
if their crosslinking degree is not too high.
Another synthetic procedure leading to PAA-hydrogels
involves the preparation of a linear PAA carrying primary
amino pendants, such as the amphoteric one (NH2–BAC)
prepared by polyaddition of monoprotonated EDA to BAC
(Scheme 3) [34]. This PAA can be used as multifunctional
crosslinking agent in the place of diamines [35].
Amphoteric PAAs, whose polymer chain contains amide,
amine, and carboxylate groups in regular sequence, can
be considered in a sense protein-like synthetic materials.
In fact, they exhibit good compatibility with proteins, as
for instance albumin. It has also been demonstrated that
diﬀerent molecules and biomolecules, as oligopeptides and
proteins [36], are capable of reproducing the receptorial sites
of proteins playing a fundamental role in cell adhesion, such
as fibronectin, laminin, and vitronectin [37]. Among these,
the tripeptide RGD is presently the most popular [38].
Recently a peptidomimetic PAA, labeled AGMA1, has
been obtained by polyaddition reaction of 2,2-bis(acryl-
amido)acetic acid and agmatine (4-aminobutyl guanidine)
[39–41]. As reported in Figure 1, AGMA1 carries guanidine
and carboxyl groups and shows a strong structural resem-
blance to the RGD sequence.
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Figure 1: Structure of agmatine containing amphoteric poly(amidoamine) (right part) compared to the RGD tripeptide sequence.
Table 2: Acid-base properties of AGMA1.
PAA name and structure pKa I.P.
Percentage of charged units IC50
B16F10 cell
pH = 5.5 pH = 7.4 (mg/mL)
NH
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N
H
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pKa1 = 2.25
pKa2 = 7.45
pKa3 = 12.1
10.0 55% (+) 90% (+) >5
Agmatine-containing PAAs hydrogels, easily obtained
using 4-aminobutyl guanidine as amine monomer, are fully
cytocompatible and also show remarkable adhesion and
proliferation properties towards several cell lines [42].
Agmatine contains a primary amino group and a
guanidine group carrying five potentially mobile hydrogens
that might participate in the polyaddition reaction. It is,
therefore, a potential cross-linking agent in PAA synthesis
like primary diamines as EDA. Nevertheless, a large diﬀer-
ence in basic properties exists between the amine and the
guanidine groups of agmatine. The latter has pKa > 12,
much higher than that of any aliphatic amine, and remains
protonated under the conditions employed in PAA synthesis
(Table 2).
Degradation tests carried out on selected PAA hydrogels
under conditions mimicking the body fluids (pH 7.4 and
37◦C) reveal that their degradation products are completely
nontoxic [42]. The mechanism of PAAs degradation seems
to be purely hydrolytic as no vinyl groups, such as those
that would be derived from a β-elimination reaction, can
be determined. Furthermore, degradation seems not to be
aﬀected by the presence of isolated lysosomal enzymes at pH
5.5 [43, 44].
3. Poly(amidoamine) Hydrogels as
Substrates for Cell Culturing
In the last few years the progress of biological sciences has
led to outstanding developments in the field of cell culturing
in vitro. Several new techniques, such as cell microarray or
cells on chips, require reliable support materials with good
biocompatibility and cell adhesion, preferentially disposable
and simple to use [45, 46]. Traditionally, cells culturing
has been performed on two-dimensional substrates or on
the surface of tissue analogs. Currently, various polymer-
based materials, that is, polystyrene (PS), polycarbonate
(PC), and polypropylene (PP), are applied as common bulk
materials in two-dimensional cell culture systems, such as
cell culture dishes and cell culture membranes. Tissue culture
polystyrene (TCPS) is the most common cell culture sub-
strate due to its easy processability and optical transparency,
but it still needs to be modified with poly(D-lysine) to
ensure cell adhesion [47]. Among all the synthetic polymeric
materials that have been found to be suitable substrates for
cell culturing, special attention has been recently given to
hydrogels. Hydrogels present unique tissue-like properties
for interactions with living cells [23, 48], such as water
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content and permeability to oxygen and metabolites. In
principle, fully synthetic hydrogels, as opposed to naturally
derived media (e.g., gelatin, chitosan, etc.), should be more
advantageous, coupling the aforementioned properties with
the possibility of complete control over hydrogel composi-
tion, crosslinking, and swelling. Hydrogels can be produced
with tailored shape and thickness, even in 3D structures, and
their surface can be patterned with lithographic techniques
[49, 50]. Moreover, hydrogels can be fittingly functionalized
with biomolecules for obtaining customized properties. Cell
adhesion on fully synthetic hydrogels, however, is still an
issue for many of these materials, such as PHEMA or
crosslinked PEG derivatives [51]. A number of chemical
and physical modifications have been proposed to overcome
this problem, often relying on modification of the synthetic
surface with biological or biomimetic moieties, as peptides
or proteins [52] typically, arginine-glycine-aspartate (RGD).
The process of cell adhesion to a substrate, both on
the natural ECM and synthetic materials, is mediated by
interactions between surface ligands and cell receptors, such
as transmembrane integrins and proteoglycans [53]. The
tripeptide RGD, present in several ECM proteins, has been
the object of intensive research in the last years [54]. In
fact, several studies have shown that this tripeptide, and
some of its analogues, can interact with adhesion-regulating
proteins of the integrin family and play a role in promoting
cell adhesion and spreading, mimicking the eﬀect of some
ECM proteins, such as fibronectin or vitronectin [55–57].
The overall action mechanism is still not completely clear,
but some studies have associated it to the conformation of
the guanidine side group of arginine, and its distance and
angle from the acidic pendant of aspartic acid [58, 59].
Modification of chemical structures in order to include an
RGD or RGD-like group has been proposed for a number
of applications where cells interaction is desired to enhance
adhesion or recognition by cellular receptors [60, 61].
Diﬀerent PAA hydrogels have been tested as substrates for
cell culture. They have been prepared using diﬀerent cross-
linkers, such as EDA, 1,10-diaminododecane, or the linear
NH2–BAC carrying primary amino pendants (Table 3).
Cytotoxicity tests have been carried out by the direct
contact method with fibroblast cell lines on the hydrogels
both in their native state (i.e., as free bases), and as salts with
acids of diﬀerent strength, namely, hydrochloric, sulfuric,
acetic, and lactic acid. This has been done in order to
ascertain if there is any counterion-specific influence on
cytotoxicity. It has been found that all the amphoteric PAA
hydrogels considered are cytobiocompatible both as free
bases and salts (Figure 2), and their biological performance
is independent of the counterion’s nature [33] (Figure 3).
Degradation tests have been performed on selected
hydrogels samples under controlled conditions simulating
biological environments, that is, Dulbecco medium at pH
7.4 and 37◦C. All samples degrade completely and dissolve
within 10 days. The degradation products of all samples have
demonstrated to be noncytotoxic [33].
PAA-AG1 and PAA-AG2 are bioactive in terms of allow-
ing cell adhesion and further proliferation. The morphology
of cells grown onto the surfaces of both hydrogels is
comparable with that of cells grown on TCPS used as control.
In all cases, cell confluence has been reached after 10 days
from the beginning of the experiments [42] (Figure 4).
Swelling tests have demonstrated that all PAA hydrogels
have a high swelling capability. This property, not unex-
pected considering the hydrophilic and ionic nature of all
investigated PAA hydrogels, ensures an eﬃcient diﬀusion of
low molecular weight substances, thus facilitating purifica-
tion processes consisting in extensive extraction with water.
However, the mechanical strength of the hydrogels in the
swollen form is modest and the materials appear relatively
fragile. The swelling of PAA hydrogels protonated with
diﬀerent acids is still very high, and not significantly diﬀerent
from that of the corresponding free bases, with the exception
of the sulfates, which are slightly less swollen.
A systematic comparative study of the response of an
epithelial cell line has been performed on AGMA1-EDA
hydrogels, on nonfunctionalized amphoteric ISA23-EDA
hydrogels, and tissue culture plastic substrates [62, 65].
As previously pointed out, the AGMA1 repeating units
(Figure 1) are very similar to the well-known adhesion-
modulating RGD peptide sequence. Since ISA23 does not
carry any guanidine pendant group, it is expected to show
no significant cell adhesion properties [33] and is used as a
nonfunctionalized control. In order to make the hydrogels
more handy, a new bilayered system has been designed,
prepared and tested. It is composed by a functionalized glass
support covered with a thin hydrogel layer. MDCK cells
have been plated on the two types of hydrogels and on
TCPS. Within 1 hour after plating, no evident diﬀerences
are observed between AGMA1-EDA and ISA23-EDA, and the
amount of adhered cells on these substrates is significantly
lower than on TCPS (Figure 5). After 3 hours, the trend is
substantially diﬀerent, and the adhesion on AGMA1-EDA is
comparable to that on TCPS (within one standard deviation)
whereas on ISA23-EDA remains definitely lower (Figure 5).
After 1-2 days, eﬀective MDCK cells proliferation on
TCPS is observed, whereas this process on AGMA1-EDA
appears to be slowed down (Figure 6).
After 3 days, meanwhile the cells on TCPS achieve con-
fluence, the cells on AGMA1-EDA form clusters and no
confluence is observed as reported in Figure 7.
This eﬀect may be explained considering that, despite the
fact that PAA hydrogel layer are supported by a rigidmaterial,
cells probably experience a more compliant substrate than
TCPS. Optical images indicate that the cells adhered on
AGMA1-EDA are less spread with respect to TCPS. This
behavior could be ascribed to the occurrence of opposite
stimuli to the cells: the compliance of the hydrogel surface,
which can prevent a strong cell-substratum interaction and
stress fiber formation, and the presence of integrin ligands,
which favors a more eﬀective cell-substratum adhesion. The
behavior of the actin stress fibers on the diﬀerent substrates
is shown in Figure 8. Slower actin stress fiber formation on
AGMA1-EDA and ISA23-EDA matches the slower spreading
on these hydrogels. Chemical properties can participate with
physical characteristics of substrates to aﬀect cell adhesion.
It has been shown that the presentation of integrin ligands
in a clusterized form enables the formation of focal contacts
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Table 3: Partial structures of PAA hydrogels.
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Table 3: Continued.
Code Structure Reference
PAA-ED3
N N
H
N
O O
N
H
N
H
N
O O
N N
H
N
O O
N
H
N
H
N
O O
O
O
N
H
N
H
COOH COOH
COOHCOOH (CH2)2
(CH2)2
NHBu
BuHN
[33]
PAA-ED4
N N
H
N
O O
N
H
N
H
N
O O
N N
H
N
O O
N
H
N
O O
O
O
(CH2)2(CH2)2
N
H
COOHCOOH
COOH COOH
OctHN
NHOct
N
H
N
H
[33]
PAA-AG1
N N
H
N
O O
N N
H
N
O O
NH2
N N
H
N
H
N
O O
N N
H
N
H
N
O O
COOH
N
H
N
H
(CH2)10
HN
NH2
HN
NH
COOH
COOH COOH
CH3
CH3
NH
[42]
8 International Journal of Polymer Science
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and stress fibers [66] and determines cell spreading [67].
A uniform low density of integrin ligands, instead, is
unable to support stress fiber formation [66]. Therefore,
slower spreading and stress fiber formation on AGMA1-EDA
hydrogels could be also due to a more uniform (i.e. not
clusterized) presentation of integrin ligands compared to the
TCPS. It is also interesting to note that on ISA23-EDA cell
islands often show membrane structures as filopodia and
lamellipodia indicating not stable focal contacts and a
tendency to cell migration [68].
4. PAA Hydrogels for Microfluidics and
Lab-on-Chip Applications
Microfluidics deals with the precise control and manipula-
tion of fluids that are geometrically constrained to a small,
typically submillimeter, scale. It is a multidisciplinary field
intersecting engineering, physics, chemistry, microtechnol-
ogy, and biotechnology, with practical applications to the
design of systems in which such small volumes of fluids will
be used.
Microfluidics has emerged at the beginning of the
1980s and is used in the development of DNA chips, lab-
on-chip technology, micropropulsion, and microthermal
technologies [69–71].
In addition to functionalizing biomaterials with ECM-
derived cell adhesive molecules, there is emerging evidence
indicating that the surface topography, stiﬀness, and electri-
cal properties play an important role in cells adhesion and
growth [72]. Based on these premises, ISA23-EDA hydrogels
have been used for the preparation of patterned substrate
using a scanning electron microscope. The method consists
of exposing dry hydrogel films to electron beam (computer
assisted) in high vacuum chamber [63]. Fluorescent labelled,
FITC or TRITC, proteins such as BSA, the hormone
EGF FITC, and the biomolecule Phalloidin-TRITC, attach
selectively to an electron-beam-modified surface in a dose
dependent manner. Higher exposure doses lead to a higher
protein or biomolecules attachment. Cells lines, such as
MDCK and PC12, have been plated on the patterned
surface. MDCK cells growth is observed along all surfaces,
independently of pattern or other physic, and chemical
modifications. The PC12 cell line, able to diﬀerentiate
into neural cells when induced by NGF, presents a strong
preference for the electron-beam-modified substrate. A 24-
hours-PC12 cell culture, NGF non-treated, has been grown
on the top of a hydrogel patterned with a chess-like area
according to Figure 9 (total area 600 × 600 μm). Containing
alternate exposed and nonexposed squares (100 × 100 μm),
84% of the total cells (400 cells) are in the electron-beam-
exposed squares (Figure 9) [63].
By exploiting the selective attachment growth and dif-
ferentiation of PC12 cells on microwells connected by thin
channels, we have fabricated a neural network of single cells
connected by neurites extending along the microchannels
[63]. The fine control of this neural network is further
strengthened by the fact that the number of outcoming
neurites is determined by the number of microchannels
originating from each microwell (Figure 10).
E-beam lithography on PAA hydrogels opens up the
opportunity of producing multifunctional microfluidics
devices supported on a small glass chip and incorporat-
ing complex topographies, allowing precise control of the
growth and organization of individual cells and providing
the capability to study physiologic and pharmacologic
responses at a single cell level.
5. PAA Hydrogels as Scaffolds for
Peripheral Nerve Regeneration
Peripheral nerve injuries present a significant clinical chal-
lenge across the world [73]. Injuries to the peripheral
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Figure 2: Results of the cytotoxicity tests of PAA-ED2, PAA-DD and PAA-ED3 hydrogels, as free base and ammonium salts, carried out on
fibroblast cells by means of the direct contact method [33].
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Figure 3: Morphology of mouse embryo fibroblasts in the cell
proliferation experiment carried out by the direct contact method
in the presence of PAA-DD as lactate ammonium salt [33].
PAA-AG2
(a)
PAA-AG1
(b)
Figure 4:Morphology of mouse embryo fibroblasts grown on PAA-
AG2 and PAA-AG1 after 10 days of culture [42].
nervous system are common and are a major source of
disability, impairing the ability to move muscles and/or feel
normal sensations or resulting in painful neuropathies. Due
Time (hr)
0
10
20
30
40
50
60
0.5 1 2 3 4
ISA23-EDA
AGMA1-EDA
TCPS
∗∗
∗∗
∗∗
∗∗
∗∗N
or
m
al
iz
ed
po
ly
go
n
al
-l
ik
e
ce
lls
(%
)
Figure 5: MDCK cells adhesion versus time on ISA23-EDA,
AGMA1-EDA, and TCPS [62].
to the diﬃculties in treating such injuries, many patients are
left without any benefit of medical intervention. Even among
the patients who receive treatment for traumatic peripheral
nerve injuries, more than 50% show no measurable signs
of recovery or else suﬀer from drastically reduced muscle
strength [74].
After nerve trauma, the standard clinical operating
procedure consists of opposing the two nerve ends and suture
them together without generating tension where possible.
When the defect is so large that the severed nerve ends cannot
be directly sutured, nerve injury is bridged by autologous
nerve grafting. While autografts are the best clinical bridges
available today because they are biocompatible, nontoxic and
provide a support structure to promote axonal adhesion,
there are many drawbacks to this procedure. These include
the need for a secondary surgery, loss of donor site function,
limited availability, modality mismatch (arising from a
sensory nerve being used to repair a motor or mixed nerve),
and neuroma formation at the donor or graft site.
Various tissue engineering strategies have been used to
influence diﬀerent aspects of the regenerative process with
hope for functional recovery using natural and synthetic
tubular scaﬀolds. The design criteria for fabrication of scaf-
folds should address various factors including composition
[75] and dimensions of the tubular scaﬀold [76], the addition
of exogenous factors such as fibrin precursors [77] and
growth factors, the incorporation of glial cells, most often
Schwann cells and fibroblasts [78, 79], the elastic modulus,
permeability, topography, swelling ratio, degradation rate,
size, and clearance of the degradation products [80]. In
particular the elastic modulus of the scaﬀold should be at
least 1,200 kPa in order to resist compressive and tensile
forces that are generated both during the surgery as well as
from surrounding tissue after implantation [81]. Diﬀerent
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Figure 6: Optical microscopy images showing time evolution of MDCK cells on ISA23-EDA, AGMA1-EDA and TCPS [62].
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(b)
Figure 7: Optical microscopy images showing MDCK on TCPS and AGMA1-EDA at 72 hour after seeding [62].
natural and synthetic materials have been used to facilitate
nerve regeneration. Among natural tubular scaﬀolds, auto-
genous venous and arterial nerve grafts have been the most
successful in achieving functional recovery across 10-mm
nerve gaps [82–84]. Venous grafts remain intact throughout
the process of nerve regeneration and are easier to extract
compared to arterial grafts [82]. While natural materials
have good biocompatibility, they often collapse when used
in longer nerve gaps. Additionally, issues related to the
limited availability of these explants, as well as autograft-
triggered immune response, are a few among many reasons
that prompted exploration of alternative materials to direct
nerve growth [85]. Synthetic tubular scaﬀolds have similar
advantages to natural scaﬀolds but additionally provide
mechanical and structural control [86]. In the recent past,
several guidance techniques using artificial nerve conduits
have been developed to guide nerve regeneration towards
the distal stump [87]. The isolated environment provided
by guidance channels helps confinement and concentrate
neurotrophic factors that are released by supporting cells
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Figure 8: Immunofluorescence analysis of actin cytoskeleton and focal contacts of TCPS or hydrogel MDCK growing cells [62].
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Figure 9: PC12 adhesion on electron-beam-exposed areas [63].
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Figure 10: Confocal microscopy images of PC12 cells grown on electron-beam-lithography-patterned network of microwells (10mm
diameter) connected by microchannels (1mm width). The cells were treated with NGF (for 48 hours) and immunostained with DAPI
(cell nuclei, blue), FITC antivinculin antibody (focal contacts, red), and TRITC phalloidin (actin filaments, red) [63].
while protecting the axons against collapse and invasion
from immune cells [82]. The use of guidance channels
eliminates functional loss at the donor site, a condition
that is commonly associated to autografts. Initial studies
employing the use of short impermeable silicone tubes have
shown promising nerve regeneration across 3mm gaps [88],
although significant fibrosis and nerve compression have
been subsequently associated with the use of these tubes
[89–91]. Biodegradable polymers such as poly(L-lactic acid),
polyglycolic acid, and poly(lactic-co-glycolic) acid have been
originally the materials of choice for synthesizing conduits,
due to their relative abundance and applicability [92–101].
In addition to poly(esters), biodegradable poly(urethane)
[102–104], poly(organo-phosphazene) [16], and poly(3-
hydroxybutyrate) [105–107] have shown a capacity for guid-
ing regeneration. Nevertheless, these materials do not fulfill
all the requirements that a scaﬀold for in vivo application
should have. For instance, a common inconvenience of
biodegradable polyesters is to cause inflammation in the
surrounding tissues giving rise to a local concentration of
acids upon degradation.
In recent years, special attention has been given to hydro-
gels. Hydrogels exhibit overall properties similar to those of
soft tissues, having tunable elasticity, nutrient permeability,
biocompatibility, and low interfacial tension. Among natural
hydrogels, gelatin-based tubular scaﬀolds [108], alginate-
based capillary hydrogels [109], and multichannel collagen
nerve conduits [110] have been used to guide axonal
growth in animal experiments. Synthetic hydrogels include
PEG [111] and poly(2-hydroxyethyl methacrylate-co-methyl
methacrylate) [112]. Although these materials have shown
promising results in terms of nerve regeneration, their
properties such as permeability, degradability, and mechani-
cal strength are not yet satisfactory [113].
AGMA1-EDA hydrogels have a definite potential as
biomimetic materials and deserve to be further considered
for diﬀerent biotechnological applications such as substrates
for cell culture [62]. Unfortunately, their mechanical prop-
erties are not satisfactory in view of a use as scaﬀolds
for tissue engineering, in that their strength is still very
low and they are very soft and breakable on handling. To
overcome this problem, a new synthetic method has been
developed leading to second-generation AGMA1 hydrogels
with similar composition and exhibiting the same biological
properties but with improved mechanical strength [64]. In
particular, a diﬀerent two-step synthetic pathway has been
followed as reported in Scheme 4. In the first step an acryloyl
end-capped linear AGMA1 oligomer is synthesized using a
controlled excess of the bisacrylamide; in the second step
the oligomer is photopolymerized by UV irradiation pro-
ducing AGMA1-UV hydrogels with the required mechanical
characteristics.
Hydrogel tubes of diﬀerent dimensions (length 10–
30mm, 3mm external diameter, and 0.5–1.2mm internal
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Figure 11: AGMA1 tubular hydrogels obtained by UV photopolymerization [64].
diameter) are obtained (Figure 11); however, the preferred
dimensions for rat implantation are 10mm length and 1mm
inner diameter [64].
Cross-linked PAAs, obtained by ethylenediamine as
cross-linking agent, swell in water giving very soft hydrogels
[33, 42, 62, 65]. Swelling tests carried out on the AGMA1-UV
hydrogels in doubly distilled water and 0.1M PBS solution
pH 7.4 show a 200% absorption in both cases, 3 times lower
than the AGMA1-EDA hydrogels.
AGMA1-UV tubular scaﬀolds have been tested in vivo as
conduit for nerve regeneration in living rats. The right sciatic
nerve of the rats has been cut in the middle, and hydrogel
conduit having 10mm length and 1mm inner diameters
implanted leaving the nerve gap of 5mm (Figure 12). All
rats have survived, and no complications related to operation
occurred, since all wounds have healed spontaneously [64].
The progression of the nerve regeneration has been
extensively analyzed at diﬀerent time points, namely, 30, 90,
and 180 days after surgery [64]. 30 days after implantation
the conduit appears well integrated and no dislocations are
observed. The regenerated nerve is resistant to mechanical
traction showing no evidence of interruption. No apparent
signs of inflammatory reaction or serum infiltrate are found,
even if a thin fibrotic sheet surrounding the conduit is
observed. Regeneration between the upper and lower nerve
stump occurs inside the scaﬀold guide as demonstrated by
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Figure 12: Normal intact right sciatic nerve was cut in the middle (a), removing 4-5mm nervous tissue. AGMA1 hydrogel tube has been
used to regenerate the gap (c) [64].
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Figure 13: Toluidine-blue semithin transverse section of regenerating nerves in the medial part of the nerve guide at 30 (a), 90 (b), and 180
(c) days after surgery [64].
the presence of nerve fibers filling the original gap. The
conduit is largely degraded but not completely reabsorbed,
since two large scaﬀold fragments (h) are embedded in the
epineurium surrounding the nerve (Figure 13(a)). At 90 days
after surgery, a complete nerve structure is evident with some
detritus still included in the fibrotic tissue around the nerve
(Figure 13(b)), whereas at 180 days the scaﬀold is grossly
reabsorbed, with only a few detritus in the surrounding
epineurium (Figure 13(c)).
Morphological evaluations have been focused on 30 days
after surgery, since the nerve regeneration is apparently
satisfactory and not significantly diﬀerent from that observed
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Figure 14: Immunofluorescence image of the regenerated nerve
inside the hydrogel tube at 30 (a) and 90 (b) days after surgery [64].
at 90 and 180 days after implantation [64]. The axonal
regeneration at 30 days is confirmed by immunofluorescent
analysis of longitudinal sections of the sciatic nerve stump
through the conduit.
Nerve fibers have been labeled in green with anti neu-
rofilament M/H antibody and Schwann cells nuclei stained
in blue with nuclear marker DAPI. Figure 14(a) shows the
continuity of green labeling for the heavy chain of axon
neurofilaments. A stronger neurofilament immunopositivity
at 90 days after surgery is consistent with a higher, complete
axonal regeneration (Figure 14(b)).
6. Conclusions and Perspectives
PAAs constitute a family of highly hydrophilic ionic polymers
that are easily synthesized and can be designed to be bio-
compatible and degradable in the body fluids. Linear PAAs
are usually water soluble. Cross-linked PAAs can be obtained
by several means, forming highly swollen hydrogels some
of which definitely warrant potential as scaﬀolds for tissue
engineering applications both in vitro and in vivo, being
highly biocompatible and biodegradable to nontoxic, self-
buﬀered products that do not elicit inflammatory response
from the surrounding tissues.
In more general terms, PAAs are highly versatile func-
tional polymers whose biotechnological applications are still
waiting to be fully exploited.
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